127 related articles for article (PubMed ID: 9863018)
1. Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma.
Kawate S; Takenoshita S; Ohwada S; Mogi A; Fukusato T; Makita F; Kuwano H; Morishita Y
Int J Oncol; 1999 Jan; 14(1):127-31. PubMed ID: 9863018
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of transforming growth factor beta type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma.
Osawa H; Shitara Y; Shoji H; Mogi A; Kuwano H; Hagiwara K; Takenoshita S
Int J Oncol; 2000 Oct; 17(4):723-8. PubMed ID: 10995883
[TBL] [Abstract][Full Text] [Related]
3. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the transforming growth factor-beta signaling pathway in hepatocellular carcinomas induced endogenously and exogenously in rats.
Sasaki Y; Tsujiuchi T; Murata N; Tsutsumi M; Konishi Y
Jpn J Cancer Res; 2001 Jan; 92(1):16-22. PubMed ID: 11173539
[TBL] [Abstract][Full Text] [Related]
6. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
[TBL] [Abstract][Full Text] [Related]
7. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
[TBL] [Abstract][Full Text] [Related]
9. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
10. Frequent loss of SMAD4/DPC4 protein in colorectal cancers.
Salovaara R; Roth S; Loukola A; Launonen V; Sistonen P; Avizienyte E; Kristo P; Järvinen H; Souchelnytskyi S; Sarlomo-Rikala M; Aaltonen LA
Gut; 2002 Jul; 51(1):56-9. PubMed ID: 12077092
[TBL] [Abstract][Full Text] [Related]
11. Lack of frameshift mutations at coding mononucleotide repeats in hepatocellular carcinoma in Japanese patients.
Saeki A; Tamura S; Ito N; Kiso S; Matsuda Y; Yabuuchi I; Kawata S; Matsuzawa Y
Cancer; 2000 Mar; 88(5):1025-9. PubMed ID: 10699890
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma.
Kawate S; Ohwada S; Hamada K; Koyama T; Takenoshita S; Morishita Y; Hagiwara K
Int J Mol Med; 2001 Jul; 8(1):49-52. PubMed ID: 11408948
[TBL] [Abstract][Full Text] [Related]
13. MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma.
Maesawa C; Tamura G; Nishizuka S; Iwaya T; Ogasawara S; Ishida K; Sakata K; Sato N; Ikeda K; Kimura Y; Saito K; Satodate R
Jpn J Cancer Res; 1997 Apr; 88(4):340-3. PubMed ID: 9197523
[TBL] [Abstract][Full Text] [Related]
14. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
[TBL] [Abstract][Full Text] [Related]
15. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the Smad2 and Smad4 genes in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Tsujiuchi T; Sasaki Y; Tsutsumi M; Konishi Y
Mol Carcinog; 2000 Oct; 29(2):87-91. PubMed ID: 11074605
[TBL] [Abstract][Full Text] [Related]
17. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
19. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
[TBL] [Abstract][Full Text] [Related]
20. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.
Kawabata M; Inoue H; Hanyu A; Imamura T; Miyazono K
EMBO J; 1998 Jul; 17(14):4056-65. PubMed ID: 9670020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]